Follow
Jacopo Boni
Jacopo Boni
Postdoctoral fellow, IDIBELL
Verified email at idibell.cat
Title
Cited by
Cited by
Year
The DYRK family of kinases in cancer: molecular functions and therapeutic opportunities
J Boni, C Rubio-Perez, N López-Bigas, C Fillat, S de la Luna
Cancers 12 (8), 2106, 2020
652020
DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth
J Luna, J Boni, M Cuatrecasas, X Bofill-De Ros, E Núñez-Manchón, ...
Gut 68 (8), 1465-1476, 2019
582019
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
F Mateo, EJ Arenas, H Aguilar, J Serra-Musach, GR De Garibay, J Boni, ...
Oncogene 36 (19), 2737-2749, 2017
412017
Lymphangioleiomyomatosis biomarkers linked to lung metastatic potential and cell stemness
G Ruiz de Garibay, C Herranz, A Llorente, J Boni, J Serra-Musach, ...
PLoS One 10 (7), e0132546, 2015
212015
Study of breast cancer incidence in patients of lymphangioleiomyomatosis
O Nuñez, A Román, SR Johnson, Y Inoue, M Hirose, Á Casanova, ...
Breast Cancer Research and Treatment 156, 195-201, 2016
122016
A decade of RAD51C and RAD51D germline variants in cancer
J Boni, A Idani, C Roca, L Feliubadaló, E Tomiak, E Weber, WD Foulkes, ...
Human mutation 43 (3), 285-298, 2022
102022
Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness
G Ruiz de Garibay, C Herranz, A Llorente, J Boni, J Serra-Musach, ...
Plos one 13 (11), e0207586, 2018
12018
Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability
E Simo Cheyou, J Boni, J Boulais, E Pinedo-Carpio, A Malina, ...
PLoS Genetics 18 (11), e1010495, 2022
2022
RAD51C and RAD51D germline mutations are associated to susceptibility to multiple cancers
J Boni, A Idani, E Weber, E Tomiak, W Foulkes, Z el Haffaf, B Rivera
EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 426-426, 2022
2022
A decade of RAD51C/D: Germline pathogenic variants and their phenotypic landscape
J Boni, A Idani, C Roca, L Feliubadaló, E Tomiak, E Weber, W Foulkes, ...
Authorea Preprints, 2021
2021
Dyrk1a in cancer: good or evil? defining properties of dyrk1a kinase as a novel tumor driver
J Boni
Universitat Pompeu Fabra, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–11